APIChangelogInfo
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-
Stock
Insider transactions
AXOGEN
tastytradeTrade AXGN
AXGN Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-50510152025040k80k120k160k200k240k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-22
2025-05-23
TYNDALL JOSEPH
M - Exercise
Stock Option (right to purchase)
-12,850
$6.00
-77,100
1
$499.16M
2025-05-22
2025-05-23
TYNDALL JOSEPH
S - Sale
Common Stock
-20,062
$11.00
-221K
2
$499.16M
2025-05-22
2025-05-23
TYNDALL JOSEPH
M - Exercise
Common Stock
12,850
$6.00
77,100
1
$499.16M
2025-05-19
2025-05-23
TYNDALL JOSEPH
S - Sale
Common Stock
-2,525
$12.00
-30,300
1
$499.16M
2025-05-22
2025-05-22
TYNDALL JOSEPH
S - Sale
-32,339
$11.00
-356K
1
$499.16M
2025-05-12
2025-05-16
HARTLEY LINDSEY MARIE
CFO
A - Grant
Restricted Stock Units
26,000
$0.00
1
$499.16M
2025-03-25
2025-03-26
DEVINNEY ERICK WAYNE
Chief Innovation Officer
A - Grant
Restricted Stock Units
38,000
$0.00
1
$499.16M
2025-03-25
2025-03-26
KEMP JENS
Chief Marketing Officer
A - Grant
Restricted Stock Units
38,000
$0.00
1
$499.16M
2025-03-25
2025-03-26
BEGAN MARC
EVP & General Counsel
A - Grant
Restricted Stock Units
55,000
$0.00
1
$499.16M
2025-03-25
2025-03-26
DALE MICHAEL
Chief Executive Officer
A - Grant
Restricted Stock Units
176K
$0.00
1
$499.16M
2025-03-19
2025-03-19
DEVINNEY ERICK WAYNE
Chief Innovation Officer
S - Sale
Common Stock
-15,111
$18.00
-272K
1
$499.16M
2025-03-16
2025-03-19
DEVINNEY ERICK WAYNE
Chief Innovation Officer
M - Exercise
Restricted Stock Units
-32,462
$0.00
3
$499.16M
2025-03-16
2025-03-19
DEVINNEY ERICK WAYNE
Chief Innovation Officer
M - Exercise
Common Stock
32,462
$0.00
3
$499.16M
2025-03-04
2025-03-05
KEMP JENS
Chief Marketing Officer
F - Tax
Common Stock
-4,003
$18.00
-72,054
1
$499.16M
2025-03-04
2025-03-05
BEGAN MARC
EVP & General Counsel
F - Tax
Common Stock
-5,901
$18.00
-106K
1
$499.16M
2025-03-03
2025-03-05
WENDELL AMY MCBRIDE
S - Sale
Common Stock
-5,000
$20.00
-100K
1
$499.16M
2025-03-01
2025-03-05
BEGAN MARC
EVP & General Counsel
M - Exercise
Common Stock
22,500
$0.00
1
$499.16M
2025-03-01
2025-03-05
BEGAN MARC
EVP & General Counsel
M - Exercise
Restricted Stock Units
-22,500
1
$499.16M
2025-02-25
2025-03-05
KEMP JENS
Chief Marketing Officer
F - Tax
Common Stock
-814
$16.00
-13,024
1
$499.16M
2025-02-22
2025-03-05
KEMP JENS
Chief Marketing Officer
M - Exercise
Common Stock
2,500
$0.00
1
$499.16M
2025-03-04
2025-03-04
DEVINNEY ERICK WAYNE
Chief Innovation Officer
F - Tax
Common Stock
-8,296
$18.00
-149K
1
$499.16M
2025-02-28
2025-03-04
DEVINNEY ERICK WAYNE
Chief Innovation Officer
M - Exercise
Common Stock
24,799
$0.00
1
$499.16M
2025-03-03
2025-03-03
AMY MCBRIDE-WENDELL
S - Sale
-5,000
$20.00
-100K
1
$499.16M
2025-02-25
2025-02-26
KEMP JENS
Chief Marketing Officer
F - Tax
Common Stock
-814
$16.00
-13,024
1
$499.16M
2025-02-25
2025-02-26
BEGAN MARC
EVP & General Counsel
F - Tax
Common Stock
-814
$17.00
-13,838
1
$499.16M
2025-02-25
2025-02-26
DEVINNEY ERICK WAYNE
Chief Innovation Officer
F - Tax
Common Stock
-972
$17.00
-16,524
1
$499.16M
2025-02-22
2025-02-26
DEVINNEY ERICK WAYNE
Chief Innovation Officer
A - Grant
Common Stock
2,500
$0.00
1
$499.16M
2025-02-22
2025-02-26
KEMP JENS
Chief Marketing Officer
M - Exercise
Common Stock
2,500
$0.00
1
$499.16M
2025-02-22
2025-02-26
BEGAN MARC
EVP & General Counsel
A - Grant
Common Stock
2,500
$0.00
1
$499.16M
2025-01-21
2025-01-21
ZADEREJ KAREN
CEO
S - Sale
-220K
$18.00
-3.96M
1
$499.16M
2025-01-14
2025-01-14
ZADEREJ KAREN
CEO
S - Sale
-100K
$18.00
-1.80M
1
$499.16M
2025-01-06
2025-01-06
NAOR NIR
CFO
F - Tax
Common Stock
-39,132
$15.00
-587K
1
$499.16M
2024-08-08
2025-01-06
TYNDALL JOSEPH
P - Purchase
Common Stock
2,525
$11.00
27,775
1
$499.16M
2024-11-07
2024-11-07
ZADEREJ KAREN
CEO
S - Sale
-70,000
$13.00
-910K
1
$499.16M
2024-09-16
2024-09-17
THOMAS PAUL
A - Grant
Common Stock
2,875
1
$499.16M
2024-09-13
2024-09-13
DEVINNEY ERICK WAYNE
Chief Innovation Officer
A - Grant
Common Stock
2,500
$0.00
1
$499.16M
2024-09-05
2024-09-05
ZADEREJ KAREN
CEO
S - Sale
-150K
$13.00
-1.95M
1
$499.16M
2024-09-01
2024-09-04
TYNDALL JOSEPH
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
WENDELL AMY MCBRIDE
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
WENDELL AMY MCBRIDE
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
JOHNSON JOHN
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
BURKE WILLIAM MR.
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
BURKE WILLIAM MR.
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
JOHNSON JOHN
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
LEVINE ALAN
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
LEVINE ALAN
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
NEELS GUIDO
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
NEELS GUIDO
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
THOMAS PAUL
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
THOMAS PAUL
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-09-01
2024-09-04
TYNDALL JOSEPH
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-08-21
2024-08-21
DONOVAN MICHAEL PATRICK
VP Operations
S - Sale
-28,003
$12.00
-336K
1
$499.16M
2024-08-13
2024-08-13
GREG FREITAG
S - Sale
-15,000
$11.00
-165K
1
$499.16M
2024-08-12
2024-08-12
ZADEREJ KAREN
CEO
S - Sale
-200K
$10.00
-2.00M
1
$499.16M
2024-08-09
2024-08-09
DALE MICHAEL
CEO and President
A - Grant
Performance Stock Units
450K
$0.00
1
$499.16M
2024-06-06
2024-06-10
WENDELL AMY MCBRIDE
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
BURKE WILLIAM MR.
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
BURKE WILLIAM MR.
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
JOHNSON JOHN
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
JOHNSON JOHN
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
LEVINE ALAN
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
LEVINE ALAN
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
NEELS GUIDO
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
NEELS GUIDO
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
THOMAS PAUL
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
THOMAS PAUL
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
TYNDALL JOSEPH
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
TYNDALL JOSEPH
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
WEILER KATHY JOHNSON
A - Grant
Employee Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-06
2024-06-10
WEILER KATHY JOHNSON
A - Grant
Common Stock
10,653
1
$499.16M
2024-06-06
2024-06-10
WENDELL AMY MCBRIDE
A - Grant
Stock Option (right to purchase)
18,248
$0.00
1
$499.16M
2024-06-04
2024-06-06
FREITAG GREGORY GENE
M - Exercise
Restricted Stock Units
-11,904
$0.00
1
$499.16M
2024-06-04
2024-06-06
FREITAG GREGORY GENE
M - Exercise
Common Stock
11,904
$0.00
1
$499.16M
2024-03-21
2024-03-25
ZADEREJ KAREN
CEO
S - Sale
Common Stock
-39,280
$8.00
-314K
3
$499.16M
2024-03-21
2024-03-25
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Common Stock
2,500
$0.00
1
$499.16M
2024-03-21
2024-03-25
DEVINNEY ERICK WAYNE
Chief Innovation Officer
S - Sale
Common Stock
-4,578
$8.00
-36,624
3
$499.16M
2024-03-21
2024-03-25
DONOVAN MICHAEL PATRICK
VP Operations
S - Sale
Common Stock
-6,033
$8.00
-48,264
3
$499.16M
2024-03-21
2024-03-25
SCOPELIANOS ANGELO
Chief R&D Officer
S - Sale
Common Stock
-6,881
$8.00
-55,048
3
$499.16M
2024-03-16
2024-03-25
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Common Stock
25,406
$0.00
2
$499.16M
2024-03-16
2024-03-25
ZADEREJ KAREN
CEO
M - Exercise
Restricted Stock Units
-110K
$0.00
3
$499.16M
2024-03-16
2024-03-25
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
110K
$0.00
3
$499.16M
2024-03-16
2024-03-25
DEVINNEY ERICK WAYNE
Chief Innovation Officer
M - Exercise
Restricted Stock Units
-18,675
$0.00
3
$499.16M
2024-03-16
2024-03-25
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Restricted Stock Units
-24,575
$0.00
3
$499.16M
2024-03-16
2024-03-25
DEVINNEY ERICK WAYNE
Chief Innovation Officer
M - Exercise
Common Stock
18,675
$0.00
3
$499.16M
2024-03-16
2024-03-25
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
24,575
$0.00
3
$499.16M
2024-03-16
2024-03-25
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Restricted Stock Units
-27,906
$0.00
3
$499.16M
2024-03-07
2024-03-08
DONOVAN MICHAEL PATRICK
VP Operations
S - Sale
Common Stock
-36,310
$9.00
-327K
1
$499.16M
2024-03-07
2024-03-08
FREITAG GREGORY GENE
S - Sale
Common Stock
-25,000
$9.00
-225K
1
$499.16M
2024-03-07
2024-03-07
GREG FREITAG
S - Sale
-25,000
$9.00
-225K
1
$499.16M
2024-03-01
2024-03-05
DEVINNEY ERICK WAYNE
Chief Innovation Officer
A - Grant
Common Stock
50,000
1
$499.16M
2024-02-22
2024-02-23
BEGAN MARC
EVP and General Counsel
A - Grant
Performance Stock Units
68,600
$0.00
1
$499.16M
2024-02-22
2024-02-23
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Performance Stock Units
68,600
$0.00
1
$499.16M
2024-02-22
2024-02-23
KEMP JENS
Chief Marketing Officer
A - Grant
Performance Stock Units
68,600
$0.00
1
$499.16M
2024-02-06
2024-02-06
MARTINEZ MARIA
Chief Human Resources Officer
S - Sale
-21,000
$10.00
-210K
1
$499.16M
2023-12-20
2024-01-11
WEILER KATHY JOHNSON
A - Grant
Stock Option (right to purchase)
65,476
$7.00
458K
1
$499.16M
2024-01-01
2024-01-04
NAOR NIR
CFO
A - Grant
Common Stock
300K
1
$499.16M
2023-12-11
2023-12-13
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-12,500
$8.00
-100K
3
$499.16M
2023-10-13
2023-10-13
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
D - Sale to Issuer
Common Stock
-864
$4.00
-3,456
1
$499.16M
2023-10-13
2023-10-13
DONOVAN MICHAEL PATRICK
VP Operations
D - Sale to Issuer
Common Stock
-1,403
$4.00
-5,612
1
$499.16M
2023-10-13
2023-10-13
MARIANI PETER
EVP & Chief Financial Officer
D - Sale to Issuer
Common Stock
-3,263
$4.00
-13,052
1
$499.16M
2023-10-13
2023-10-13
MARTINEZ MARIA
Chief Human Resources Officer
D - Sale to Issuer
Common Stock
-1,403
$4.00
-5,612
1
$499.16M
2023-10-13
2023-10-13
SCOPELIANOS ANGELO
Chief R&D Officer
D - Sale to Issuer
Common Stock
-1,403
$4.00
-5,612
1
$499.16M
2023-07-18
2023-10-13
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2023-07-18
2023-10-13
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Common Stock
1,579
$0.00
1
$499.16M
2023-07-18
2023-10-13
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2023-07-18
2023-10-13
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Common Stock
3,709
$0.00
1
$499.16M
2023-07-18
2023-10-13
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2023-07-18
2023-10-13
ZADEREJ KAREN
CEO
A - Grant
Common Stock
22,076
$0.00
1
$499.16M
2023-09-06
2023-09-08
WENDELL AMY MCBRIDE
P - Purchase
Common Stock
10,000
$6.00
60,000
1
$499.16M
2023-09-01
2023-09-07
BURKE WILLIAM MR.
A - Grant
Common Stock
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
BURKE WILLIAM MR.
A - Grant
Employee Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
FREITAG GREGORY GENE
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
FREITAG GREGORY GENE
A - Grant
Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
JOHNSON JOHN
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
JOHNSON JOHN
A - Grant
Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
LEVINE ALAN
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
LEVINE ALAN
A - Grant
Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
NEELS GUIDO
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
NEELS GUIDO
A - Grant
Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
THOMAS PAUL
A - Grant
Employee Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
THOMAS PAUL
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
TYNDALL JOSEPH
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
TYNDALL JOSEPH
A - Grant
Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-09-01
2023-09-07
WENDELL AMY MCBRIDE
A - Grant
Restricted Stock Units
11,904
$0.00
1
$499.16M
2023-09-01
2023-09-07
WENDELL AMY MCBRIDE
A - Grant
Stock Option (right to purchase)
20,436
$0.00
1
$499.16M
2023-08-24
2023-08-25
BURKE WILLIAM MR.
A - Grant
Common Stock
6,000
$6.00
36,000
1
$499.16M
2023-08-23
2023-08-25
BURKE WILLIAM MR.
P - Purchase
Common Stock
10,000
$7.00
70,000
1
$499.16M
2023-08-16
2023-08-18
NEELS GUIDO
P - Purchase
Common Stock
10,000
$6.00
60,000
1
$499.16M
2023-06-01
2023-06-05
JOHNSON JOHN
M - Exercise
Restricted Stock Units
-6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
JOHNSON JOHN
M - Exercise
Common Stock
6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
LEVINE ALAN
M - Exercise
Restricted Stock Units
-6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
LEVINE ALAN
M - Exercise
Common Stock
6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
NEELS GUIDO
M - Exercise
Restricted Stock Units
-6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
NEELS GUIDO
M - Exercise
Common Stock
6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
THOMAS PAUL
M - Exercise
Restricted Stock Units
-6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
THOMAS PAUL
M - Exercise
Common Stock
6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
WENDELL AMY MCBRIDE
M - Exercise
Restricted Stock Units
-6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
WENDELL AMY MCBRIDE
M - Exercise
Common Stock
6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
FREITAG GREGORY GENE
S - Sale
Common Stock
-41,980
$9.00
-378K
2
$499.16M
2023-06-01
2023-06-05
FREITAG GREGORY GENE
M - Exercise
Restricted Stock Units
-6,459
$0.00
1
$499.16M
2023-06-01
2023-06-05
FREITAG GREGORY GENE
M - Exercise
Common Stock
6,459
$0.00
1
$499.16M
2023-06-02
2023-06-02
GREG FREITAG
S - Sale
-29,480
$9.00
-265K
1
$499.16M
2023-06-01
2023-06-01
GREG FREITAG
S - Sale
-12,500
$9.00
-113K
1
$499.16M
2023-05-23
2023-05-24
FREITAG GREGORY GENE
S - Sale
Common Stock
-7,468
$9.00
-67,212
2
$499.16M
2023-05-22
2023-05-22
FREITAG GREGORY GENE
S - Sale
-7,468
$9.00
-67,212
1
$499.16M
2023-05-12
2023-05-16
WENDELL AMY MCBRIDE
M - Exercise
Common Stock
28,750
$9.00
259K
2
$499.16M
2023-05-12
2023-05-16
WENDELL AMY MCBRIDE
M - Exercise
Stock Option (right to buy)
-28,750
$0.00
2
$499.16M
2023-03-16
2023-03-20
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Employee Stock Option (right to purchase)
94,500
$0.00
1
$499.16M
2023-03-16
2023-03-20
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Restricted Stock Units
65,600
$0.00
1
$499.16M
2023-03-16
2023-03-20
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Employee Stock Option (right to purchase)
113K
$0.00
2
$499.16M
2023-03-16
2023-03-20
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Employee Stock Option (right to purchase)
78,000
$0.00
1
$499.16M
2023-03-16
2023-03-20
ZADEREJ KAREN
CEO
A - Grant
Employee Stock Option (right to purchase)
179K
$0.00
1
$499.16M
2023-03-16
2023-03-20
ZADEREJ KAREN
CEO
A - Grant
Restricted Stock Units
112K
$0.00
1
$499.16M
2023-03-16
2023-03-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-2,769
$8.00
-22,152
2
$499.16M
2023-03-16
2023-03-20
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-2,769
$8.00
-22,152
2
$499.16M
2023-03-16
2023-03-20
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-7,038
$8.00
-56,304
2
$499.16M
2023-03-16
2023-03-20
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-4,270
$8.00
-34,160
4
$499.16M
2023-03-16
2023-03-20
OTTINGER BRADLEY
General Counsel and CCO
F - Tax
Common Stock
-2,634
$8.00
-21,072
2
$499.16M
2023-03-16
2023-03-20
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-3,907
$8.00
-31,256
3
$499.16M
2023-03-16
2023-03-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Restricted Stock Units
8,900
$0.00
2
$499.16M
2023-03-16
2023-03-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
8,900
$0.00
2
$499.16M
2023-03-16
2023-03-20
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Restricted Stock Units
-8,900
$0.00
2
$499.16M
2023-03-16
2023-03-20
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
8,900
$0.00
2
$499.16M
2023-03-16
2023-03-20
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Restricted Stock Units
-20,750
$0.00
2
$499.16M
2023-03-16
2023-03-20
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,750
$0.00
2
$499.16M
2023-03-16
2023-03-20
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Restricted Stock Units
14,517
$0.00
4
$499.16M
2023-03-16
2023-03-20
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Common Stock
14,517
$0.00
4
$499.16M
2023-03-16
2023-03-20
OTTINGER BRADLEY
General Counsel and CCO
M - Exercise
Restricted Stock Units
-8,463
$0.00
2
$499.16M
2023-03-16
2023-03-20
OTTINGER BRADLEY
General Counsel and CCO
M - Exercise
Common Stock
8,463
$0.00
2
$499.16M
2023-03-16
2023-03-20
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Restricted Stock Units
-13,750
$0.00
3
$499.16M
2023-03-16
2023-03-20
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Common Stock
13,750
$0.00
3
$499.16M
2023-03-16
2023-03-20
ZADEREJ KAREN
CEO
M - Exercise
Restricted Stock Units
-37,975
$0.00
2
$499.16M
2023-03-16
2023-03-20
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
37,975
$0.00
2
$499.16M
2023-03-16
2023-03-20
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Restricted Stock Units
54,100
$0.00
1
$499.16M
2023-03-16
2023-03-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Employee Stock Option (right to purchase)
64,000
$0.00
1
$499.16M
2023-03-16
2023-03-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Restricted Stock Units
46,300
$0.00
1
$499.16M
2023-03-16
2023-03-20
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Employee Stock Option (right to purchase)
63,500
$0.00
1
$499.16M
2023-03-16
2023-03-20
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Restricted Stock Units
48,500
$0.00
1
$499.16M
2023-02-01
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-14,550
$9.00
-131K
1
$499.16M
2023-02-01
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-20,940
$0.00
1
$499.16M
2023-02-01
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,940
$5.00
105K
1
$499.16M
2023-01-31
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,939
$5.00
105K
1
$499.16M
2023-01-31
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-20,939
$0.00
1
$499.16M
2023-01-31
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-14,320
$10.00
-143K
1
$499.16M
2023-01-30
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-20,939
$0.00
1
$499.16M
2023-01-30
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-14,111
$10.00
-141K
1
$499.16M
2023-01-30
2023-02-01
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,939
$5.00
105K
1
$499.16M
2023-01-27
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-20,940
$10.00
-209K
1
$499.16M
2023-01-27
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-20,940
$0.00
1
$499.16M
2023-01-27
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,940
$5.00
105K
1
$499.16M
2023-01-26
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-20,939
$0.00
1
$499.16M
2023-01-26
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,939
$5.00
105K
1
$499.16M
2023-01-26
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-20,939
$10.00
-209K
1
$499.16M
2023-01-25
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-20,939
$0.00
1
$499.16M
2023-01-25
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
20,939
$5.00
105K
1
$499.16M
2023-01-25
2023-01-27
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-20,939
$10.00
-209K
1
$499.16M
2022-12-27
2022-12-29
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Restricted Stock Units
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
BILLET ISABELLE
Chief Strategy and BD Officer
F - Tax
Common Stock
-327
$9.00
-2,943
1
$499.16M
2022-12-27
2022-12-29
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-187
$9.00
-1,683
1
$499.16M
2022-12-27
2022-12-29
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-286
$9.00
-2,574
1
$499.16M
2022-12-27
2022-12-29
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-649
$9.00
-5,841
1
$499.16M
2022-12-27
2022-12-29
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-286
$9.00
-2,574
1
$499.16M
2022-12-27
2022-12-29
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-286
$9.00
-2,574
1
$499.16M
2022-12-27
2022-12-29
BILLET ISABELLE
Chief Strategy and BD Officer
M - Exercise
Restricted Stock Units
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
BILLET ISABELLE
Chief Strategy and BD Officer
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Restricted Stock Units
750
$0.00
1
$499.16M
2022-12-27
2022-12-29
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
750
$0.00
1
$499.16M
2022-12-27
2022-12-29
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Restricted Stock Units
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Restricted Stock Units
2,625
$0.00
1
$499.16M
2022-12-27
2022-12-29
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
2,625
$0.00
1
$499.16M
2022-12-27
2022-12-29
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Restricted Stock Units
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2022-12-27
2022-12-29
ZADEREJ KAREN
CEO
M - Exercise
Restricted Stock Units
4,400
$0.00
1
$499.16M
2022-12-27
2022-12-29
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
4,400
$0.00
1
$499.16M
2022-12-27
2022-12-28
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Employee Stock Option (right to buy)
-20,000
$0.00
1
$499.16M
2022-12-27
2022-12-28
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-10,784
$9.00
-97,056
1
$499.16M
2022-12-27
2022-12-28
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
20,000
$5.00
100K
1
$499.16M
2022-12-15
2022-12-16
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to buy)
-26,746
$0.00
1
$499.16M
2022-12-15
2022-12-16
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Employee Stock Option (right to purchase)
-19,364
$0.00
1
$499.16M
2022-12-15
2022-12-16
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
26,746
$5.00
134K
1
$499.16M
2022-12-14
2022-12-16
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-8,930
$11.00
-98,230
1
$499.16M
2022-12-14
2022-12-16
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
19,364
$5.00
96,820
1
$499.16M
2022-12-13
2022-12-15
TYNDALL JOSEPH
A - Grant
Stock Option (right to purchase)
43,171
$11.00
475K
1
$499.16M
2022-11-16
2022-11-18
MARIANI PETER
EVP & Chief Financial Officer
S - Sale
Common Stock
-10,649
$12.00
-128K
1
$499.16M
2022-11-14
2022-11-16
FREITAG GREGORY GENE
S - Sale
Common Stock
-13,000
$13.00
-169K
1
$499.16M
2022-11-08
2022-11-10
FREITAG GREGORY GENE
S - Sale
Common Stock
-13,000
$13.00
-169K
1
$499.16M
2022-08-10
2022-08-11
FREITAG GREGORY GENE
S - Sale
Common Stock
-8,886
$10.00
-88,860
1
$499.16M
2022-08-08
2022-08-08
FREITAG GREGORY GENE
S - Sale
Common Stock
-13,046
$10.00
-130K
1
$499.16M
2022-08-04
2022-08-08
FREITAG GREGORY GENE
S - Sale
Common Stock
-24,000
$11.00
-264K
1
$499.16M
2022-07-25
2022-07-26
FREITAG GREGORY GENE
F - Tax
Common Stock
-30,296
$9.00
-273K
1
$499.16M
2022-07-25
2022-07-26
FREITAG GREGORY GENE
M - Exercise
Employee Stock Option (right to purchase)
-83,000
$0.00
1
$499.16M
2022-07-25
2022-07-26
FREITAG GREGORY GENE
M - Exercise
Common Stock
83,000
$3.00
249K
1
$499.16M
2022-07-19
2022-07-20
BILLET ISABELLE
Chief Strategy and BD Officer
D - Sale to Issuer
Common Stock
-751
$8.00
-6,008
1
$499.16M
2022-07-19
2022-07-20
ZADEREJ KAREN
CEO
D - Sale to Issuer
Common Stock
-9,081
$8.00
-72,648
1
$499.16M
2022-07-19
2022-07-20
SCOPELIANOS ANGELO
Chief R&D Officer
D - Sale to Issuer
Common Stock
-657
$8.00
-5,256
1
$499.16M
2022-07-19
2022-07-20
SANDBERG ERIC
Chief Commercial Officer
D - Sale to Issuer
Common Stock
-1,125
$8.00
-9,000
1
$499.16M
2022-07-19
2022-07-20
MARTINEZ MARIA
Chief Human Resources Officer
D - Sale to Issuer
Common Stock
-657
$8.00
-5,256
1
$499.16M
2022-07-19
2022-07-20
MARIANI PETER
EVP & Chief Financial Officer
D - Sale to Issuer
Common Stock
-947
$8.00
-7,576
1
$499.16M
2022-07-19
2022-07-20
DONOVAN MICHAEL PATRICK
VP Operations
D - Sale to Issuer
Common Stock
-657
$8.00
-5,256
1
$499.16M
2022-07-19
2022-07-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
D - Sale to Issuer
Common Stock
-405
$8.00
-3,240
1
$499.16M
2022-07-18
2022-07-20
ZADEREJ KAREN
CEO
A - Grant
Common Stock
22,076
$0.00
1
$499.16M
2022-07-18
2022-07-20
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2022-07-18
2022-07-20
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Common Stock
1,579
$0.00
1
$499.16M
2022-07-18
2022-07-20
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2022-07-18
2022-07-20
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Common Stock
3,710
$0.00
1
$499.16M
2022-07-18
2022-07-20
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2022-07-18
2022-07-20
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Common Stock
4,408
$0.00
1
$499.16M
2022-07-18
2022-07-20
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Common Stock
2,571
$0.00
1
$499.16M
2022-07-19
2022-07-19
BURKE WILLIAM MR.
A - Grant
Stock Option (right to purchase)
59,395
$8.00
475K
1
$499.16M
2022-06-01
2022-06-03
FREITAG GREGORY GENE
A - Grant
Employee Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
FREITAG GREGORY GENE
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
GOLD MARK STEPHEN
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
GOLD MARK STEPHEN
A - Grant
Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
JOHNSON JOHN
A - Grant
Employee Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
JOHNSON JOHN
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
LEVINE ALAN
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
LEVINE ALAN
A - Grant
Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
NEELS GUIDO
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
NEELS GUIDO
A - Grant
Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
THOMAS PAUL
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
THOMAS PAUL
A - Grant
Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
THOMAS PAUL
A - Grant
Common Stock
3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
WENDELL AMY MCBRIDE
A - Grant
Restricted Stock Units
6,459
$0.00
1
$499.16M
2022-06-01
2022-06-03
WENDELL AMY MCBRIDE
A - Grant
Stock Option (right to purchase)
11,811
$0.00
1
$499.16M
2022-06-01
2022-06-03
OTTINGER BRADLEY
General Counsel and CCO
F - Tax
Common Stock
-3,775
$0.00
1
$499.16M
2022-06-01
2022-06-03
FREITAG GREGORY GENE
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
FREITAG GREGORY GENE
M - Exercise
Common Stock
3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
GOLD MARK STEPHEN
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
GOLD MARK STEPHEN
M - Exercise
Common Stock
3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
LEVINE ALAN
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
LEVINE ALAN
M - Exercise
Common Stock
3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
NEELS GUIDO
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
NEELS GUIDO
M - Exercise
Common Stock
3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
OTTINGER BRADLEY
General Counsel and CCO
M - Exercise
Restricted Stock Units
-15,500
$0.00
1
$499.16M
2022-06-01
2022-06-03
OTTINGER BRADLEY
General Counsel and CCO
M - Exercise
Common Stock
15,500
$0.00
1
$499.16M
2022-06-01
2022-06-03
THOMAS PAUL
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
WENDELL AMY MCBRIDE
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-06-01
2022-06-03
WENDELL AMY MCBRIDE
M - Exercise
Common Stock
3,036
$0.00
1
$499.16M
2022-03-30
2022-04-01
BLACKFORD QUENTIN
M - Exercise
Restricted Stock Units
-3,036
$0.00
1
$499.16M
2022-03-30
2022-04-01
BLACKFORD QUENTIN
M - Exercise
Common Stock
3,036
$0.00
1
$499.16M
2022-03-16
2022-03-18
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
25,950
$0.00
1
$499.16M
2022-03-16
2022-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Employee Stock Option (right to purchase)
21,784
$0.00
1
$499.16M
2022-03-16
2022-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Restricted Stock Units
23,354
$0.00
1
$499.16M
2022-03-16
2022-03-18
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Employee Stock Option (right to purchase)
23,738
$0.00
1
$499.16M
2022-03-16
2022-03-18
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Restricted Stock Units
25,450
$0.00
1
$499.16M
2022-03-16
2022-03-18
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Employee Stock Option (right to purchase)
34,745
$0.00
1
$499.16M
2022-03-16
2022-03-18
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Restricted Stock Units
37,250
$0.00
1
$499.16M
2022-03-16
2022-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
A - Grant
Employee Stock Option (right to purchase)
33,419
$0.00
1
$499.16M
2022-03-16
2022-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
A - Grant
Restricted Stock Units
35,829
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Employee Stock Option (right to purchase)
103K
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Restricted Stock Units
76,780
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Employee Stock Option (right to purchase)
30,348
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Restricted Stock Units
32,536
$0.00
1
$499.16M
2022-03-16
2022-03-18
OTTINGER BRADLEY
General Counsel and CCO
A - Grant
Employee Stock Option (right to purchase)
41,948
$0.00
1
$499.16M
2022-03-16
2022-03-18
OTTINGER BRADLEY
General Counsel and CCO
A - Grant
Restricted Stock Units
44,973
$0.00
1
$499.16M
2022-03-16
2022-03-18
OTTINGER BRADLEY
General Counsel and CCO
A - Grant
Common Stock
2,563
$0.00
1
$499.16M
2022-03-16
2022-03-18
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Employee Stock Option (right to purchase)
60,576
$0.00
1
$499.16M
2022-03-16
2022-03-18
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Restricted Stock Units
62,910
$0.00
1
$499.16M
2022-03-16
2022-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Employee Stock Option (right to purchase)
39,700
$0.00
1
$499.16M
2022-03-16
2022-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Restricted Stock Units
42,563
$0.00
1
$499.16M
2022-03-16
2022-03-18
ZADEREJ KAREN
CEO
A - Grant
Employee Stock Option (right to purchase)
317K
$0.00
1
$499.16M
2022-03-16
2022-03-18
ZADEREJ KAREN
CEO
A - Grant
Restricted Stock Units
170K
$0.00
1
$499.16M
2022-03-16
2022-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
F - Tax
Common Stock
-2,447
$8.00
-19,576
1
$499.16M
2022-03-16
2022-03-18
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-1,497
$8.00
-11,976
1
$499.16M
2022-03-16
2022-03-18
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-1,512
$8.00
-12,096
1
$499.16M
2022-03-16
2022-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
F - Tax
Common Stock
-1,502
$8.00
-12,016
1
$499.16M
2022-03-16
2022-03-18
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-2,769
$8.00
-22,152
1
$499.16M
2022-03-16
2022-03-18
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-3,239
$8.00
-25,912
1
$499.16M
2022-03-16
2022-03-18
OTTINGER BRADLEY
General Counsel and CCO
F - Tax
Common Stock
-648
$8.00
-5,184
1
$499.16M
2022-03-16
2022-03-18
SANDBERG ERIC
Chief Commercial Officer
F - Tax
Common Stock
-1,512
$8.00
-12,096
1
$499.16M
2022-03-16
2022-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-2,770
$8.00
-22,160
1
$499.16M
2022-03-16
2022-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
M - Exercise
Restricted Stock Units
-8,500
$0.00
1
$499.16M
2022-03-16
2022-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
M - Exercise
Common Stock
8,500
$0.00
1
$499.16M
2022-03-16
2022-03-18
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Restricted Stock Units
-6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Restricted Stock Units
-6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
M - Exercise
Restricted Stock Units
-6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
M - Exercise
Common Stock
6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Restricted Stock Units
-11,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
11,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Restricted Stock Units
-12,866
$0.00
2
$499.16M
2022-03-16
2022-03-18
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Common Stock
12,866
$0.00
2
$499.16M
2022-03-16
2022-03-18
OTTINGER BRADLEY
General Counsel and CCO
M - Exercise
Restricted Stock Units
-2,563
$0.00
1
$499.16M
2022-03-16
2022-03-18
SANDBERG ERIC
Chief Commercial Officer
M - Exercise
Restricted Stock Units
-6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
SANDBERG ERIC
Chief Commercial Officer
M - Exercise
Common Stock
6,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Restricted Stock Units
-11,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Common Stock
11,000
$0.00
1
$499.16M
2022-03-16
2022-03-18
ZADEREJ KAREN
CEO
M - Exercise
Restricted Stock Units
-25,950
$0.00
1
$499.16M
2022-02-22
2022-02-24
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
15,000
$5.00
75,000
2
$499.16M
2022-02-22
2022-02-24
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Employee Stock Option (right to purchase)
-15,000
$0.00
2
$499.16M
2022-02-15
2022-02-17
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Common Stock
1,181
$0.00
1
$499.16M
2022-02-15
2022-02-17
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Common Stock
1,325
$0.00
1
$499.16M
2022-02-15
2022-02-17
ZADEREJ KAREN
CEO
A - Grant
Common Stock
13,978
$0.00
1
$499.16M
2022-02-15
2022-02-17
BILLET ISABELLE
Chief Strategy and BD Officer
F - Tax
Common Stock
-447
$8.00
-3,576
1
$499.16M
2022-02-15
2022-02-17
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-357
$8.00
-2,856
1
$499.16M
2022-02-15
2022-02-17
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-205
$8.00
-1,640
1
$499.16M
2022-02-15
2022-02-17
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
F - Tax
Common Stock
-357
$8.00
-2,856
1
$499.16M
2022-02-15
2022-02-17
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-950
$8.00
-7,600
1
$499.16M
2022-02-15
2022-02-17
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-400
$8.00
-3,200
1
$499.16M
2022-02-15
2022-02-17
SANDBERG ERIC
Chief Commercial Officer
F - Tax
Common Stock
-762
$8.00
-6,096
1
$499.16M
2022-02-15
2022-02-17
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-400
$8.00
-3,200
1
$499.16M
2022-02-15
2022-02-17
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Common Stock
1,325
$0.00
1
$499.16M
2022-02-15
2022-02-17
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Common Stock
2,531
$0.00
1
$499.16M
2022-02-15
2022-02-17
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Common Stock
1,325
$0.00
1
$499.16M
2022-02-15
2022-02-17
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
A - Grant
Common Stock
1,181
$0.00
1
$499.16M
2022-02-15
2022-02-17
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Common Stock
3,157
$0.00
1
$499.16M
2022-02-15
2022-02-17
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Common Stock
675
$0.00
1
$499.16M
2021-12-27
2021-12-29
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Restricted Stock Units
-1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
SCOPELIANOS ANGELO
Chief R&D Officer
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
ZADEREJ KAREN
CEO
M - Exercise
Restricted Stock Units
-4,400
$0.00
1
$499.16M
2021-12-27
2021-12-29
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
4,400
$0.00
1
$499.16M
2021-12-27
2021-12-29
BILLET ISABELLE
Chief Strategy and BD Officer
M - Exercise
Restricted Stock Units
-1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
BILLET ISABELLE
Chief Strategy and BD Officer
F - Tax
Common Stock
-326
$10.00
-3,260
1
$499.16M
2021-12-27
2021-12-29
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-187
$10.00
-1,870
1
$499.16M
2021-12-27
2021-12-29
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-286
$10.00
-2,860
1
$499.16M
2021-12-27
2021-12-29
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
F - Tax
Common Stock
-286
$10.00
-2,860
1
$499.16M
2021-12-27
2021-12-29
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-648
$10.00
-6,480
1
$499.16M
2021-12-27
2021-12-29
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-286
$10.00
-2,860
1
$499.16M
2021-12-27
2021-12-29
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-286
$10.00
-2,860
1
$499.16M
2021-12-27
2021-12-29
ZADEREJ KAREN
CEO
F - Tax
Common Stock
-1,752
$10.00
-17,520
1
$499.16M
2021-12-27
2021-12-29
BILLET ISABELLE
Chief Strategy and BD Officer
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Restricted Stock Units
-750
$0.00
1
$499.16M
2021-12-27
2021-12-29
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
750
$0.00
1
$499.16M
2021-12-27
2021-12-29
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Restricted Stock Units
-1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
M - Exercise
Restricted Stock Units
-1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
M - Exercise
Common Stock
1,150
$0.00
1
$499.16M
2021-12-27
2021-12-29
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Restricted Stock Units
-2,625
$0.00
1
$499.16M
2021-12-27
2021-12-29
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
2,625
$0.00
1
$499.16M
2021-12-27
2021-12-29
MARTINEZ MARIA
Chief Human Resources Officer
M - Exercise
Restricted Stock Units
-1,150
$0.00
1
$499.16M
2021-12-20
2021-12-22
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-144
$9.00
-1,296
1
$499.16M
2021-12-20
2021-12-22
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-95
$9.00
-855
1
$499.16M
2021-12-20
2021-12-22
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
F - Tax
Common Stock
-95
$9.00
-855
1
$499.16M
2021-12-20
2021-12-22
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-757
$9.00
-6,813
1
$499.16M
2021-12-20
2021-12-22
ZADEREJ KAREN
CEO
F - Tax
Common Stock
-1,243
$9.00
-11,187
1
$499.16M
2021-12-20
2021-12-22
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Restricted Stock Units
-575
$0.00
1
$499.16M
2021-12-20
2021-12-22
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
575
$0.00
1
$499.16M
2021-12-20
2021-12-22
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Restricted Stock Units
-375
$0.00
1
$499.16M
2021-12-20
2021-12-22
DONOVAN MICHAEL PATRICK
VP Operations
M - Exercise
Common Stock
375
$0.00
1
$499.16M
2021-12-20
2021-12-22
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
M - Exercise
Restricted Stock Units
-375
$0.00
1
$499.16M
2021-12-20
2021-12-22
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
M - Exercise
Common Stock
375
$0.00
1
$499.16M
2021-12-20
2021-12-22
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Restricted Stock Units
-1,900
$0.00
1
$499.16M
2021-12-20
2021-12-22
MARIANI PETER
EVP & Chief Financial Officer
M - Exercise
Common Stock
1,900
$0.00
1
$499.16M
2021-12-20
2021-12-22
ZADEREJ KAREN
CEO
M - Exercise
Restricted Stock Units
-3,125
$0.00
1
$499.16M
2021-12-20
2021-12-22
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
3,125
$0.00
1
$499.16M
2021-12-15
2021-12-17
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Employee Stock Option (right to buy)
-10,000
$0.00
1
$499.16M
2021-12-15
2021-12-17
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-4,171
$9.00
-37,539
1
$499.16M
2021-12-15
2021-12-17
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
M - Exercise
Common Stock
10,000
$4.00
40,000
1
$499.16M
2021-11-24
2021-11-29
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to purchase)
-52,375
$9.00
-471K
1
$499.16M
2021-11-24
2021-11-29
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
52,375
$9.00
471K
1
$499.16M
2021-08-13
2021-08-16
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to buy)
-46,500
$4.00
-186K
1
$499.16M
2021-08-13
2021-08-16
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
46,500
$4.00
186K
1
$499.16M
2021-08-12
2021-08-16
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
8,254
$5.00
41,270
1
$499.16M
2021-08-12
2021-08-16
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to buy)
-8,254
$5.00
-41,270
1
$499.16M
2021-08-10
2021-08-10
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to purchase)
-75,000
$5.00
-375K
1
$499.16M
2021-08-10
2021-08-10
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
75,000
$5.00
375K
1
$499.16M
2021-08-06
2021-08-10
ZADEREJ KAREN
CEO
S - Sale
Common Stock
-41,000
$18.00
-738K
4
$499.16M
2021-07-21
2021-07-23
DONOVAN MICHAEL PATRICK
VP Operations
S - Sale
Common Stock
-1,935
$20.00
-38,700
1
$499.16M
2021-07-20
2021-07-21
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-637
$19.00
-12,103
1
$499.16M
2021-07-20
2021-07-21
BILLET ISABELLE
Chief Strategy and BD Officer
F - Tax
Common Stock
-728
$19.00
-13,832
1
$499.16M
2021-07-20
2021-07-21
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
F - Tax
Common Stock
-392
$19.00
-7,448
1
$499.16M
2021-07-20
2021-07-21
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
F - Tax
Common Stock
-637
$19.00
-12,103
1
$499.16M
2021-07-20
2021-07-21
MARIANI PETER
EVP & Chief Financial Officer
F - Tax
Common Stock
-918
$19.00
-17,442
1
$499.16M
2021-07-20
2021-07-21
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-637
$19.00
-12,103
1
$499.16M
2021-07-20
2021-07-21
SANDBERG ERIC
Chief Commercial Officer
F - Tax
Common Stock
-1,090
$19.00
-20,710
1
$499.16M
2021-07-20
2021-07-21
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-637
$19.00
-12,103
1
$499.16M
2021-07-20
2021-07-21
ZADEREJ KAREN
CEO
F - Tax
Common Stock
-8,812
$19.00
-167K
1
$499.16M
2021-07-19
2021-07-21
ZADEREJ KAREN
CEO
A - Grant
Common Stock
22,077
$0.00
1
$499.16M
2021-07-19
2021-07-21
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Common Stock
2,572
$0.00
1
$499.16M
2021-07-19
2021-07-21
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Common Stock
4,408
$0.00
1
$499.16M
2021-07-19
2021-07-21
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Common Stock
2,572
$0.00
1
$499.16M
2021-07-19
2021-07-21
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Common Stock
3,710
$0.00
1
$499.16M
2021-07-19
2021-07-21
JOHNSON JOHN
A - Grant
Stock Options (right to buy)
27,638
$0.00
1
$499.16M
2021-07-19
2021-07-21
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
A - Grant
Common Stock
2,572
$0.00
1
$499.16M
2021-07-19
2021-07-21
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Common Stock
2,572
$0.00
1
$499.16M
2021-07-19
2021-07-21
DEVINNEY ERICK WAYNE
VP Peripheral Nerve Science
A - Grant
Common Stock
1,580
$0.00
1
$499.16M
2021-07-19
2021-07-21
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Common Stock
2,572
$0.00
1
$499.16M
2021-06-17
2021-06-21
FREITAG GREGORY GENE
F - Tax
Common Stock
-8,781
$21.00
-184K
1
$499.16M
2021-06-17
2021-06-21
FREITAG GREGORY GENE
M - Exercise
Employee Stock Option (right to purchase)
-9,250
$0.00
1
$499.16M
2021-06-17
2021-06-21
FREITAG GREGORY GENE
M - Exercise
Common Stock
9,250
$19.00
176K
1
$499.16M
2021-06-04
2021-06-08
FREITAG GREGORY GENE
M - Exercise
Employee Stock Option (right to buy)
-24,000
$4.00
-96,000
1
$499.16M
2021-06-04
2021-06-08
FREITAG GREGORY GENE
M - Exercise
Common Stock
24,000
$4.00
96,000
1
$499.16M
2021-06-04
2021-06-08
MARTINEZ MARIA
Chief Human Resources Officer
S - Sale
Common Stock
-2,652
$19.00
-50,388
1
$499.16M
2021-05-19
2021-06-07
NEELS GUIDO
M - Exercise
Stock Option (right to buy)
-25,000
$4.00
-100K
1
$499.16M
2021-05-19
2021-06-07
NEELS GUIDO
M - Exercise
Stock Option (right to purchase)
-15,000
$5.00
-75,000
1
$499.16M
2021-05-19
2021-06-07
NEELS GUIDO
M - Exercise
Common Stock
40,000
$4.00
160K
2
$499.16M
2021-06-01
2021-06-03
BLACKFORD QUENTIN
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
BLACKFORD QUENTIN
A - Grant
Stock Option (right to purchase)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
FREITAG GREGORY GENE
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
FREITAG GREGORY GENE
A - Grant
Stock Option (right to purchase)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
GOLD MARK STEPHEN
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
GOLD MARK STEPHEN
A - Grant
Stock Option (right to buy)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
LEVINE ALAN
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
LEVINE ALAN
A - Grant
Stock Option (right to buy)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
NEELS GUIDO
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
NEELS GUIDO
A - Grant
Stock Option (right to purchase)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
THOMAS PAUL
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
THOMAS PAUL
A - Grant
Stock Option (right to buy)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
WENDELL AMY MCBRIDE
A - Grant
Restricted Stock Units
3,036
$0.00
1
$499.16M
2021-06-01
2021-06-03
WENDELL AMY MCBRIDE
A - Grant
Stock Option (right to purchase)
6,030
$0.00
1
$499.16M
2021-06-01
2021-06-03
BLACKFORD QUENTIN
M - Exercise
Restricted Stock Units
-6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
BLACKFORD QUENTIN
M - Exercise
Common Stock
6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
GOLD MARK STEPHEN
M - Exercise
Restricted Stock Units
-6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
GOLD MARK STEPHEN
M - Exercise
Common Stock
6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
LEVINE ALAN
M - Exercise
Restricted Stock Units
-6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
LEVINE ALAN
M - Exercise
Common Stock
6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
NEELS GUIDO
M - Exercise
Restricted Stock Units
-6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
NEELS GUIDO
M - Exercise
Common Stock
6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
WENDELL AMY MCBRIDE
M - Exercise
Restricted Stock Units
-6,173
$0.00
1
$499.16M
2021-06-01
2021-06-03
WENDELL AMY MCBRIDE
M - Exercise
Common Stock
6,173
$0.00
1
$499.16M
2021-05-26
2021-05-28
FREITAG GREGORY GENE
M - Exercise
Employee Stock Option (right to purchase)
-87,954
$7.00
-616K
4
$499.16M
2021-05-26
2021-05-28
FREITAG GREGORY GENE
M - Exercise
Stock Option (right to purchase)
-15,000
$5.00
-75,000
1
$499.16M
2021-05-26
2021-05-28
FREITAG GREGORY GENE
M - Exercise
Common Stock
103K
$7.00
721K
5
$499.16M
2021-05-19
2021-05-21
NEELS GUIDO
M - Exercise
Stock Option (right to buy)
-25,000
$4.00
-100K
1
$499.16M
2021-05-19
2021-05-21
NEELS GUIDO
M - Exercise
Stock Option (right to purchase)
-15,000
$5.00
-75,000
1
$499.16M
2021-05-19
2021-05-21
NEELS GUIDO
M - Exercise
Common Stock
40,000
$4.00
160K
2
$499.16M
2021-04-28
2021-04-30
DEVINNEY ERICK WAYNE
VP of Clin. & Trans. Sciences
M - Exercise
Employee Stock Option (right to buy)
-10,000
$3.00
-30,000
1
$499.16M
2021-04-28
2021-04-30
DEVINNEY ERICK WAYNE
VP of Clin. & Trans. Sciences
M - Exercise
Common Stock
10,000
$3.00
30,000
1
$499.16M
2021-04-16
2021-04-20
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to purchase)
-100K
$5.00
-500K
1
$499.16M
2021-04-16
2021-04-20
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
100K
$5.00
500K
1
$499.16M
2021-03-25
2021-03-29
ZADEREJ KAREN
CEO
M - Exercise
Employee Stock Option (right to buy)
-34,500
$4.00
-138K
2
$499.16M
2021-03-25
2021-03-29
ZADEREJ KAREN
CEO
M - Exercise
Common Stock
34,500
$4.00
138K
1
$499.16M
2021-03-16
2021-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Restricted Stock Units
11,800
$0.00
1
$499.16M
2021-03-16
2021-03-18
DEVINNEY ERICK WAYNE
VP, Clinical&Translational Sc
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
DEVINNEY ERICK WAYNE
VP, Clinical&Translational Sc
A - Grant
Restricted Stock Units
11,800
$0.00
1
$499.16M
2021-03-16
2021-03-18
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
DONOVAN MICHAEL PATRICK
VP Operations
A - Grant
Restricted Stock Units
11,800
$0.00
1
$499.16M
2021-03-16
2021-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
FRIEDMAN MARK LOUIS
VP Regulatory Affairs & Policy
A - Grant
Restricted Stock Units
11,800
$0.00
1
$499.16M
2021-03-16
2021-03-18
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Employee Stock Option (right to purchase)
61,000
$0.00
1
$499.16M
2021-03-16
2021-03-18
MARIANI PETER
EVP & Chief Financial Officer
A - Grant
Restricted Stock Units
30,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
MARTINEZ MARIA
Chief Human Resources Officer
A - Grant
Restricted Stock Units
24,900
$0.00
2
$499.16M
2021-03-16
2021-03-18
OTTINGER BRADLEY
General Counsel and CCO
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
OTTINGER BRADLEY
General Counsel and CCO
A - Grant
Restricted Stock Units
19,490
$0.00
2
$499.16M
2021-03-16
2021-03-18
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Employee Stock Option (right to purchase)
23,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Restricted Stock Units
11,800
$0.00
1
$499.16M
2021-03-16
2021-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Employee Stock Option (right to purchase)
34,000
$0.00
1
$499.16M
2021-03-16
2021-03-18
SCOPELIANOS ANGELO
Chief R&D Officer
A - Grant
Restricted Stock Units
16,500
$0.00
1
$499.16M
2021-03-16
2021-03-18
ZADEREJ KAREN
CEO
A - Grant
Employee Stock Option (right to purchase)
76,600
$0.00
1
$499.16M
2021-03-16
2021-03-18
ZADEREJ KAREN
CEO
A - Grant
Restricted Stock Units
50,000
$0.00
1
$499.16M
2021-02-25
2021-03-01
FREITAG GREGORY GENE
S - Sale
Common Stock
-24,000
$22.00
-528K
1
$499.16M
2021-02-18
2021-02-19
DONOVAN MICHAEL PATRICK
VP Operations
S - Sale
Common Stock
-1,808
$19.00
-34,352
1
$499.16M
2021-02-17
2021-02-18
DEVINNEY ERICK WAYNE
VP, Clinical&Translational Sc
F - Tax
Common Stock
-1,864
$19.00
-35,416
2
$499.16M
2021-02-17
2021-02-18
ZADEREJ KAREN
CEO
F - Tax
Common Stock
-7,686
$19.00
-146K
2
$499.16M
2021-02-17
2021-02-18
DONOVAN MICHAEL PATRICK
VP Operations
F - Tax
Common Stock
-797
$19.00
-15,143
2
$499.16M
2021-02-17
2021-02-18
FREITAG GREGORY GENE
F - Tax
Common Stock
-1,577
$19.00
-29,963
2
$499.16M
2021-02-17
2021-02-18
FRIEDMAN MARK LOUIS
VP, Regulatory & Quality
F - Tax
Common Stock
-951
$19.00
-18,069
2
$499.16M
2021-02-17
2021-02-18
MARIANI PETER
Chief Financial Officer
F - Tax
Common Stock
-2,954
$19.00
-56,126
2
$499.16M
2021-02-17
2021-02-18
MARTINEZ MARIA
Chief Human Resources Officer
F - Tax
Common Stock
-406
$19.00
-7,714
1
$499.16M
2021-02-17
2021-02-18
BILLET ISABELLE
Chief Strategy and BD Officer
F - Tax
Common Stock
-454
$19.00
-8,626
1
$499.16M
2021-02-17
2021-02-18
SANDBERG ERIC
Chief Commercial Officer
F - Tax
Common Stock
-903
$19.00
-17,157
1
$499.16M
2021-02-17
2021-02-18
SCOPELIANOS ANGELO
Chief R&D Officer
F - Tax
Common Stock
-406
$19.00
-7,714
1
$499.16M
2021-02-16
2021-02-18
SANDBERG ERIC
Chief Commercial Officer
A - Grant
Common Stock
2,531
$0.00
1
$499.16M
2021-02-16
2021-02-18
BILLET ISABELLE
Chief Strategy and BD Officer
A - Grant
Common Stock
1,325
$0.00
1
$499.16M